Loading...
Loading...
Of the 5 tracked institutions holding ZKH, 2 have a 3-year clone track record — 2 of them beat the S&P. Average holder's clone alpha: +8.4pt. It's a gauge of who owns the name, not just how many.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Among the 5 tracked institutional investors we monitor, ZKH (ZKH GROUP LTD) is held with a combined value of $501.74K across 169,506 shares. The largest holder is RENAISSANCE TECHNOLOGIES LLC with a position worth $266.10K. 2 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$501.74K
Total Shares Held
169,506
Institutional Holders
5
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | $266.10K | 0.00% | -1.7% |
| 2 | CITADEL ADVISORS LLC | $196.35K | 0.00% | +137.8% |
| 3 | STATE STREET CORP | $33.21K | 0.00% | +4.0% |
| 4 | FMR LLC | $5.22K | 0.00% | - |
| 5 | BlackRock, Inc. | $861 | 0.00% | - |
As of the latest SEC 13F filings, RENAISSANCE TECHNOLOGIES LLC is the largest institutional holder of ZKH with a position worth $266.10K, representing 0.00% of their portfolio. In total, 5 institutional investors hold ZKH with a combined value of $501.74K.
Institutional investors hold $501.74K worth of ZKH stock across 5 positions. The largest institutional holder is RENAISSANCE TECHNOLOGIES LLC with $266.10K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ZKH, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ZKH positions.
Last Close
$2.95
2026-07-24
YTD
-20.1%
51% of 52-week range